Kforce Healthcare, Inc. and Elsevier/MC Strategies Enhance ICD-10 Services
TAMPA, Fla., Sept. 27, 2012 (GLOBE NEWSWIRE) — Kforce Healthcare, Inc., a staffing and solutions provider for Health Information Management (HIM) services, has expanded its offerings through a collaboration with Elsevier’s MC Strategies to provide ICD-10 education, training assessments and project management services. In early 2012, Kforce Healthcare and Elsevier began offering training to more than 700 Kforce HIM consultants. Leveraging Elsevier’s unique eLearning platform, Kforce Healthcare has continued to deliver tailored training plans for these consultants through a phased approach.
Extending their collaborative services, Kforce Healthcare and Elsevier are now working together to provide organizational readiness, including coder and documentation assessments, as well as training and education for all areas affected by the ICD-10 transition.
“Now that the Department of Health and Human Services has finalized the October 1, 2014 date for ICD-10 implementation, all healthcare facilities need to evaluate their ICD-10 readiness and develop vendor relationships to help ensure there is no delay in securing experienced resources,” said Amy Simpson, Group Vice President, Kforce Healthcare, Inc. “The demand for talent in areas including technology, as well as coding and analysis, is projected to quickly escalate. Talent and time are running out for facilities that delay on preparations for the ICD-10 deadline.”
From before the go-live date and beyond, Kforce Healthcare offers specialized assistance for all stages of ICD-10 implementation including: assessments, project management, remote and onsite education and post-implementation activities. Kforce Healthcare also regularly provides compliance reviews, clinical documentation improvement services and staffing support services to assist clients in achieving a successful transition to ICD-10 and on-going compliance efforts even after the October 2014 implementation deadline.
“By collaborating with Kforce, we are able to bring our eLearning resources to Kforce consultants and to provide healthcare organizations with the preparation they need to meet the challenges of the coming ICD-10 implementation deadline,” said John Schrefer, President of Elsevier’s MC Strategies. “Only through education and training will we be able to help make this transition go smoothly for our clients.”
About Kforce Healthcare, Inc.
For more than 15 years Kforce Healthcare has offered customized business solutions for HIM services including all aspects of the coding department, revenue cycle and more. We work with more than 500 healthcare providers across the U.S., including many of the nation’s top Honor Roll Hospitals. Kforce Healthcare, Inc. is a wholly owned subsidiary of Kforce Inc. (Nasdaq:KFRC), a $1 billion firm founded in 1962. Everything we do is driven by the desire to support the financial health of healthcare organizations and the career health of our consultants. We accomplish this with an intense focus on quality processes and procedures. Health information matters. It matters to our client organizations, it matters to our consultant employees, and most of all, it matters to us.
To learn more about Kforce Healthcare’s multi stage ICD-10 solution, contact 866-230-7865 or KforceHealthcare@kforce.com, or visit http://www.kforce.com/ICD-10/ICD-10-Education.aspx.
The Kforce Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3749
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
For more information about Elsevier ICD-10 eLearning Solutions, please visit www.ICD-10online.com or call 1-866-429-3067.
Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Factors that could cause actual results to differ materially include the following: business conditions and
growth in the staffing industry and general economy; competitive factors, risks due to shifts in the market demand, including, without limitation, shifts in demand for our Technology, Finance and Accounting, Health Information Management and Government Solutions segments, as well as the market for search and flexible staffing assignments; changes in the service mix; ability of the Firm to complete acquisitions; and the risk factors listed from time to time in the Firm’s reports filed with the Securities and Exchange Commission, as well as assumptions regarding the foregoing. In particular, there can be no assurance that we will continue to increase our market share, successfully manage risks to our revenue stream and successfully put into place the people and processes that will create future success. The words “should,” “believe,” “estimate,” “expect,” “intend,” “anticipate,” “foresee,” “plan” and similar expressions and variations thereof identify certain of such forward-looking statements, which speak only as of the dates on which they were made. The Firm undertakes no obligation to publicly update or revise any forward-looking statements. As a result, such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those indicated in the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements.
AT THE FIRM: Michael Blackman Chief Corporate Development Officer 813-552-2927 MEDIA INQUIRIES REGARDING THIS RELEASE: Danielle Rotolo Copywriter & Public Relations Manager 813-552-3469